Planet 13 Holdings (PLNH) Non Operating Income (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Non Operating Income of $1.8 million for Q1 2026, down 63.23% year-over-year from $4.8 million in Q1 2025, and down 57.5% quarter-over-quarter from $4.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Non Operating Income (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Non Operating Income for 6 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 63.23% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $4.0 million (down 13.13% YoY), while the FY2025 annual figure was $7.0 million, up 7835.96% from the prior year.
- Non Operating Income fell to $1.8 million in Q1 2026 per PLNH's latest filing, from $4.2 million in the prior quarter.
- Across five years, Non Operating Income topped out at $4.8 million in Q1 2025 and bottomed at -$2.4 million in Q4 2022.
- Historically, Non Operating Income has averaged $333550.9 across 5 years, with a median of $109898.0 in 2023.
- Annual changes were most pronounced in 2022 — Non Operating Income sank 726.22% — and 2025, when it jumped 3449.35%.
- Planet 13 Holdings' Non Operating Income stood at -$2.4 million in 2022, then surged by 52.97% to -$1.1 million in 2023, then surged by 86.57% to -$149870.0 in 2024, then jumped by 2870.51% to $4.2 million in 2025, then sank by 57.5% to $1.8 million in 2026.
- Business Quant data shows PLNH's Non Operating Income at $1.8 million in Q1 2026, $4.2 million in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Planet 13 Holdings | 50.16 Mn | 33.68 Mn | 12.32 Mn | 165,613.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165,613.00 |
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 4.15 Mn |
| Sep 30, 2025 | -1.89 Mn |
| Jun 30, 2025 | -51,810.00 |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | -149,870.00 |
| Sep 30, 2024 | 403,914.00 |
| Jun 30, 2024 | -479,844.00 |
| Mar 31, 2024 | 135,214.00 |
| Dec 31, 2023 | -1.12 Mn |
| Sep 30, 2023 | 109,898.00 |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | -1.72 Mn |
| Dec 31, 2022 | -2.37 Mn |
| Sep 30, 2022 | 291,613.00 |
| Jun 30, 2022 | -2.36 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | -287,136.00 |
| Sep 30, 2021 | 6.75 Mn |